Td Asset Management Inc Amicus Therapeutics, Inc. Transaction History

Td Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$9.82 - $12.44 $491,982 - $623,244	-50,100 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$8.74 - $11.84 $141,588 - $191,808	16,200 Added 47.79%	50,100 $478,000
Q2 2021 Aug 11, 2021	BUY	$8.71 - $10.72 $295,269 - $363,408	33,900 New	33,900 $315,000
Q4 2018 Feb 01, 2019	SELL	$8.38 - $13.44 $383,544 - $615,135	-45,769 Closed	0 $0
Q3 2018 Nov 01, 2018	SELL	$11.6 - $16.54 $921,712 - $1.31 Million	-79,458 Reduced 63.45%	45,769 $553,000
Q2 2018 Jul 31, 2018	BUY	$13.13 - $17.09 $208,767 - $271,731	15,900 Added 14.54%	125,227 $1.96 Million
Q1 2018 May 11, 2018	SELL	$13.76 - $17.12 $1.49 Million - $1.86 Million	-108,427 Reduced 49.79%	109,327 $1.64 Million
Q4 2017 Feb 02, 2018	SELL	$12.51 - $16.24 $96,327 - $125,047	-7,700 Reduced 3.42%	217,754 $3.13 Million
Q3 2017 Nov 09, 2017	BUY	$11.74 - $15.78 $2.65 Million - $3.56 Million	225,454	225,454 $3.4 Million

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.56B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.